DermTech, Inc.: Nasdaq/NYSE listing notice — DermTech receives Nasdaq bid-price deficiency notice; has until Oct 14, 2024 to regain compliance

DermTech, Inc.

Received Nasdaq notice on April 15, 2024 for bid price below $1.00 for 30 consecutive business days.
Must achieve closing bid price ≥$1.00 for at least 10 consecutive business days by October 14, 2024.
If stock closes below $0.10 during compliance period, Nasdaq may issue a delisting determination.
Company may qualify for a second 180-day compliance period if other listing standards are met.
Notice does not immediately affect listing on Nasdaq Capital Market or business operations.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

DermTech, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)(iii)

Exact text from the filing

April 15, 2024, DermTech, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), closed below the minimum $1.00 per share requirement for continued inclusion under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq rules, the Company has been provided a 180-calendar day compliance pe

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001651944-24-000028

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.